Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $25.61 | 1 | 68.2% |
| Education | $11.92 | 1 | 31.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $25.61 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25.61 | 1 | ABBVIE INC. ($25.61) |
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/25/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 5 | 291 | 397 | $67,963 | $30,037 |
| 2020 | 8 | 393 | 531 | $85,230 | $31,059 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 102 | 158 | $23,432 | $11,383 | 48.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 59 | 97 | $23,413 | $10,605 | 45.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 90 | 102 | $9,372 | $4,859 | 51.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $7,239 | $2,034 | 28.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 19 | 19 | $4,507 | $1,155 | 25.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 132 | 228 | $33,373 | $13,437 | 40.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 53 | 68 | $16,054 | $5,782 | 36.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 46 | 46 | $15,608 | $4,615 | 29.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 92 | 109 | $10,619 | $4,083 | 38.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 11 | 11 | $5,007 | $1,335 | 26.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 22 | 24 | $1,848 | $933.90 | 50.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 23 | 29 | $1,110 | $547.93 | 49.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 14 | 16 | $1,611 | $325.99 | 20.2% |
About Dr. Zarah Dulce Lucas, MD
Dr. Zarah Dulce Lucas, MD is a Medical Oncology healthcare provider based in Loma Linda, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2009. The National Provider Identifier (NPI) number assigned to this provider is 1235369703.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Zarah Dulce Lucas, MD has received a total of $37.53 in payments from pharmaceutical and medical device companies, with $25.61 received in 2024. These payments were reported across 2 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($25.61).
As a Medicare-enrolled provider, Lucas has provided services to 684 Medicare beneficiaries, totaling 928 services with total Medicare billing of $61,095. Data is available for 2 years (2020–2021), covering 13 distinct procedure/service records.
Practice Information
- Specialty Medical Oncology
- Location Loma Linda, CA
- Active Since 07/19/2009
- Last Updated 07/23/2025
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1235369703
Products in Payments
- VENCLEXTA (Drug) $25.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.